Dr. Dreicer on Combining Agents With Immunotherapies

Robert Dreicer, MD
Published: Thursday, Mar 27, 2014

Robert Dreicer, MD, MS, professor of medicine at the Cleveland Clinic Lerner College of Medicine, chairman, Department of Solid Tumor Oncology, Taussig Cancer Institute, discusses combining and sequencing agents with immunotherapies for the treatment of prostate cancer.

Theoretically, many therapies with targets and toxicities that do not overlap could be used together, though this has not been studied.

Early phase II studies are being conducted looking at sipuleucel-T with or without enzalutamide or abiraterone, though they are not likely to be particularly informative, Dreicer says, as they are all tolerable therapies. Trials are not being done to answer the question as to whether combining or sequencing agents and immunotherapies can actually improve outcomes.
 
Robert Dreicer, MD, MS, professor of medicine at the Cleveland Clinic Lerner College of Medicine, chairman, Department of Solid Tumor Oncology, Taussig Cancer Institute, discusses combining and sequencing agents with immunotherapies for the treatment of prostate cancer.

Theoretically, many therapies with targets and toxicities that do not overlap could be used together, though this has not been studied.

Early phase II studies are being conducted looking at sipuleucel-T with or without enzalutamide or abiraterone, though they are not likely to be particularly informative, Dreicer says, as they are all tolerable therapies. Trials are not being done to answer the question as to whether combining or sequencing agents and immunotherapies can actually improve outcomes.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Publication Bottom Border
Border Publication
x